click below
click below
Normal Size Small Size show me how
NURS 572 Pharm 56a
Pharm Diabetes Mellitus Drug drill only
Question | Answer |
---|---|
regular insulin | quick/short insulin |
lispro | quicker/shorter insulin |
aspart | quicker/shorter insulin |
glulisine | quicker/shorter insulin |
NPH = neutral protamine hagedorn | intermediate insulin that can be mixed with quicker shorter and quick short (regular) |
detemir | long acting insulin |
glargine | super long insulin |
glipizide, safe in elderly, renal impaired | sulfonylureas - secretagogue |
glyburide | sulfonylureas - secretagogue |
glimepiride | sulfonylureas - secretagogue |
repaglinide | meglitinide - secretagogue |
nateglinide | meglitinide - secretagogue |
metformin | biguadide whose primary MOA is to decrease glycogenolysis. secondary MOA to increase receptor sensitivity. ADR lactic acidosis |
pioglitazone | glitazone whose primary MOA is increased receptor sensitivity. secondary MOA is decreased glycogenolysis. ADR hepatotoxic |
rosglitazone | glitazone whose primary MOA is increased receptor sensitivity. secondary MOA is decreased glycogenolysis. ADR hepatotoxic |
acarbose | alpha-glucosidase inhibitor |
miglitol | alpha-glucosidase inhibitor |
pramlinitide | injectible amylin mimetic |
exenatide BID | injectible incretin memetic |
liraglutide QD | injectible incretin mimetic |
sitagliptin oral QD | DPP4 inhibitor that potentiates incretin |
saxagliptin oral QD | DPP4 inhibitor that potentiates incretin |
linagliptin oral QD | DPP4 inhibitor that potentiates incretin |